Literature DB >> 3486872

Effect of phenytoin on human cerebral glucose metabolism.

W H Theodore, D Bairamian, M E Newmark, G DiChiro, R J Porter, S Larson, D Fishbein.   

Abstract

We used serial positron emission tomography scans with [18F]2-deoxyglucose to study the effect of phenytoin on human cerebral glucose metabolism in 10 patients with seizure disorders. Local CMRglu for each patient was measured in 10 regions of interest. EEGs were performed during each procedure to match scans for state of consciousness and exclude data from scans with ictal activity. Serial scans without a drug change were performed in six control patients. Metabolic rates were significantly lower in two cortical regions while patients were taking phenytoin. No significant changes on repeat scan were seen in the control population. Measured across all regions of interest, metabolic rates were 13% higher when patients were off phenytoin (p less than 0.02).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486872     DOI: 10.1038/jcbfm.1986.54

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  8 in total

1.  Regional cerebral blood flow by SPECT imaging in Sturge-Weber disease: an aid for diagnosis.

Authors:  C Chiron; C Raynaud; N Tzourio; C Diebler; O Dulac; M Zilbovicius; A Syrota
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-12       Impact factor: 10.154

Review 2.  Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?

Authors:  C S Brock; S R Meikle; P Price
Journal:  Eur J Nucl Med       Date:  1997-06

3.  CBF changes in drug naive juvenile myoclonic epilepsy patients.

Authors:  Woo Suk Tae; Eun Yeon Joo; Sun Jung Han; Kyung-Han Lee; Seung Bong Hong
Journal:  J Neurol       Date:  2007-03-12       Impact factor: 4.849

4.  Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects.

Authors:  P Maquet; D Dive; E Salmon; R von Frenckel; G Franck
Journal:  Eur J Nucl Med       Date:  1990

5.  Interictal regional cerebral blood flow during non specific activation test in partial epilepsy.

Authors:  J Valmier; J Touchon; M Baldy-Moulinier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-03       Impact factor: 10.154

6.  Effect of lamotrigine on cerebral blood flow in patients with idiopathic generalised epilepsy.

Authors:  Eun Yeon Joo; Seung Bong Hong; Woo Suk Tae; Sun Jung Han; Dae Won Seo; Kyung-Han Lee; Mann Hyung Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-10       Impact factor: 9.236

7.  Cerebral glucose metabolism in neurofibromatosis type 1 assessed with [18F]-2-fluoro-2-deoxy-D-glucose and PET.

Authors:  P Balestri; G Lucignani; A Fois; L Magliani; L Calistri; C Grana; R M Di Bartolo; D Perani; F Fazio
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

8.  Effects of Valproic Acid on Cerebral Nutrient Carriers' Expression in the Rat.

Authors:  Aniv Mann Brukner; Tamir Ben-Hur; Asaf Honig; Dana Ekstein; Sara Eyal
Journal:  Front Pharmacol       Date:  2018-09-21       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.